Andrew Balo
2009
In 2009, Andrew Balo earned a total compensation of $371.6K as Sr. V.P., Clinical Regulatory Affairs at DexCom, a 59% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $98,175 |
|---|---|
| Salary | $255,000 |
| Other | $18,402 |
| Total | $371,577 |
Balo received $255K in salary, accounting for 69% of the total pay in 2009.
Balo also received $98.2K in non-equity incentive plan and $18.4K in other compensation.
Rankings
In 2009, Andrew Balo's compensation ranked 7,766th out of 9,885 executives tracked by ExecPay. In other words, Balo earned more than 21.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,766 out of 9,885 | 21st |
Division Manufacturing | 2,905 out of 3,690 | 21st |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 452 out of 602 | 25th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 249 out of 326 | 24th |
Industry Surgical and Medical Instruments and Apparatus | 167 out of 212 | 21st |
Source: SEC filing on April 18, 2011.
Balo's colleagues
We found four more compensation records of executives who worked with Andrew Balo at DexCom in 2009.